Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
US7544799B2 · kind B2 · utility
8Cited by
9References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2006 |
| Grant date | Jun 9, 2009 |
| Priority date | — |
| Expiry date | Sep 5, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC30B7/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.